Literature DB >> 20144482

Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model.

N Geusens1, L Hering, S Verlohren, C Luyten, K Drijkoningen, M Taube, L Vercruysse, M Hanssens, R Dechend, R Pijnenborg.   

Abstract

As a follow-up to our previous study which revealed a surprisingly deeper endovascular trophoblast (ET) invasion on day 18 in a transgenic preeclamptic (PE) rat model (hAngiotensinogen female symbol x hRenin male symbol) compared to non-PE controls, we examined further changes in ET invasion and associated spiral artery (SA) remodelling at term (day 21). PE transgenic rats and non-PE reversely mated (RM) transgenic rats were compared to normal SD rats (C). Sections were stained to visualize trophoblast, fibrinoid, vascular smooth muscle (VSM) and endothelium. SA were evaluated in three depth levels in the mesometrial triangle (MT) using the KS-400 image analysis system. In separate transgenic rats, Doppler ultrasound was performed in uterine arteries, and the resistance indices (RI) were calculated. Although for the whole MT differences in ET invasion were no longer significant between the PE and C, indicating a partial catching up in C rats, there was still significantly more ET in the deepest level in the PE group as compared to the C and RM groups. At the same time the SA walls in PE rats contained significantly more fibrinoid (versus RM and C) and VSM (versus C). In all SA cross-sections, re-endothelialisation was prominent, but significantly different between PE and C group. The Doppler results showed a significantly lower RI in the arcuate uterine artery of the PE group compared to the C group. There was no evidence of elimination of deeply invaded ET at term, previously considered as a possible mechanism for restriction of vascular remodelling in human PE. The differences in vascular remodelling, previously described on day 18 by histology and Doppler data, were maintained on day 21, but there was extensive endothelial repair in the three groups. Atherosis-like lesions were observed in the three groups, most frequently in the RM group, but were never associated with placental infarcts. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144482     DOI: 10.1016/j.placenta.2010.01.011

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  22 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface.

Authors:  M J Soares; D Chakraborty; M A Karim Rumi; T Konno; S J Renaud
Journal:  Placenta       Date:  2012-01-28       Impact factor: 3.481

Review 3.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

4.  Regulatory T cells ameliorate intrauterine growth retardation in a transgenic rat model for preeclampsia.

Authors:  Lukasz Przybyl; Tarek Ibrahim; Nadine Haase; Michaela Golic; Julianna Rugor; Friedrich C Luft; Ivo Bendix; Meray Serdar; Gerd Wallukat; Anne Cathrine Staff; Dominik N Müller; Thomas Hünig; Ursula Felderhoff-Müser; Florian Herse; Babette LaMarca; Ralf Dechend
Journal:  Hypertension       Date:  2015-04-06       Impact factor: 10.190

5.  IL-1 receptor antagonist therapy mitigates placental dysfunction and perinatal injury following Zika virus infection.

Authors:  Jun Lei; Meghan S Vermillion; Bei Jia; Han Xie; Li Xie; Michael W McLane; Jeanne S Sheffield; Andrew Pekosz; Amanda Brown; Sabra L Klein; Irina Burd
Journal:  JCI Insight       Date:  2019-02-28

6.  Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats.

Authors:  Katrin Wenzel; Augustine Rajakumar; Hannelore Haase; Nele Geusens; Norbert Hubner; Herbert Schulz; Justin Brewer; Lyndsay Roberts; Carl A Hubel; Florian Herse; Lydia Hering; Fatimunnisa Qadri; Carsten Lindschau; Gerd Wallukat; Robert Pijnenborg; Harald Heidecke; Gabriela Riemekasten; Friedrich C Luft; Dominik N Muller; Babette Lamarca; Ralf Dechend
Journal:  Hypertension       Date:  2011-05-16       Impact factor: 10.190

7.  Functional changes in the uterine artery precede the hypertensive phenotype in a transgenic model of hypertensive pregnancy.

Authors:  Victor M Pulgar; Liliya M Yamaleyeva; Jasmina Varagic; Carolynne McGee; Michael Bader; Ralf Dechend; K Bridget Brosnihan
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-22       Impact factor: 4.310

Review 8.  Drug transport across the human placenta: review of placenta-on-a-chip and previous approaches.

Authors:  Rajeendra L Pemathilaka; David E Reynolds; Nicole N Hashemi
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

9.  Chromosome-substituted rat strains provide insights into the genetics of placentation.

Authors:  Toshihiro Konno; Lea A Rempel; M A Karim Rumi; Amanda R Graham; Kazuo Asanoma; Stephen J Renaud; Michael J Soares
Journal:  Physiol Genomics       Date:  2011-06-07       Impact factor: 3.107

10.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.